Literature DB >> 25894548

Abuse-deterrent opioid formulations: part of a public health strategy to reverse the opioid epidemic.

Hillary V Kunins1.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 25894548     DOI: 10.1001/jamainternmed.2015.0939

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  7 in total

Review 1.  Breaking barriers to novel analgesic drug development.

Authors:  Ajay S Yekkirala; David P Roberson; Bruce P Bean; Clifford J Woolf
Journal:  Nat Rev Drug Discov       Date:  2017-06-09       Impact factor: 84.694

Review 2.  Basic/Translational Development of Forthcoming Opioid- and Nonopioid-Targeted Pain Therapeutics.

Authors:  Nebojsa Nick Knezevic; Ajay Yekkirala; Tony L Yaksh
Journal:  Anesth Analg       Date:  2017-11       Impact factor: 5.108

3.  Human Abuse Potential of an Abuse-Deterrent (AD), Extended-Release (ER) Morphine Product Candidate (Morphine-ADER Injection-Molded Tablets) versus Extended-Release Morphine Administered Orally in Nondependent Recreational Opioid Users.

Authors:  Michael D Smith; Lynn R Webster; John Lawler; Karsten Lindhardt; Jeffrey M Dayno
Journal:  Pain Med       Date:  2017-05-01       Impact factor: 3.750

4.  Intranasal Pharmacokinetics of Morphine ARER, a Novel Abuse-Deterrent Formulation: Results from a Randomized, Double-Blind, Four-Way Crossover Study in Nondependent, Opioid-Experienced Subjects.

Authors:  Lynn R Webster; Carmela Pantaleon; Matthew Iverson; Michael D Smith; Eric R Kinzler; Stefan Aigner
Journal:  Pain Res Manag       Date:  2018-04-23       Impact factor: 3.037

Review 5.  A systematic review of strategies to improve appropriate use of opioids and to reduce opioid use disorder and deaths from prescription opioids.

Authors:  Andrea D Furlan; Nancy Carnide; Emma Irvin; Dwayne Van Eerd; Claire Munhall; Jaemin Kim; Cathy Meng Fei Li; Abdul Hamad; Quenby Mahood; Sara MacDonald
Journal:  Can J Pain       Date:  2018-07-31

6.  Oral Human Abuse Potential of Oxycodone DETERx® (Xtampza® ER).

Authors:  Ernest A Kopecky; Alison B Fleming; Naama Levy-Cooperman; Melinda O'Connor; Edward M Sellers
Journal:  J Clin Pharmacol       Date:  2016-11-01       Impact factor: 3.126

7.  Abuse-Deterrent Opioids: A Survey of Physician Beliefs, Behaviors, and Psychology.

Authors:  Nabarun Dasgupta; John R Brown; Maryalice Nocera; Allison Lazard; Svetla Slavova; Patricia R Freeman
Journal:  Pain Ther       Date:  2021-12-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.